Transplant hepatologist at University of Miami / Miami Transplant Institute. Interests include quality improvement and LGBTQ health.

First-year gastroenterology fellow at UCLA with plans to pursue advanced training in hepatology and transplant hepatology. She aspires to build a career as a clinician-researcher, with a focus on health services research aimed at addressing health inequities among patients with decompensated cirrhosis. Her research interests in health services research includes work grounded in amplifying patient perspectives to inform more equitable and patient-centered models of care.

Professor of Medicine at Mayo Clinic in Rochester, MN. Her clinical research interests center around improving access to transplant and improving long term outcomes after liver transplantation.

Dr. Brittany Bromfield earned her medical degree from the University of the West Indies in Jamaica and completed her internal medicine residency at the University of Pittsburgh Medical Education Program. She is currently a gastroenterology and hepatology fellow at Brigham and Women's Hospital. Her clinical and research interests include alcohol-related liver disease (ALD), MetALD, MASLD, and obesity, with a focus on the intersection of metabolic dysfunction and addiction.

Gina Madison is the Executive Director and a Board Member of Liver Education Advocates (LEA), a national nonprofit dedicated to advancing liver health through education, awareness, advocacy, and patient support. Since joining LEA in 2019, she has helped expand the organization's national reach through innovative education programs, community partnerships, and culturally responsive initiatives that empower individuals affected by liver disease.

I am a pediatric gastroenterologist with expertise in pediatric nutrition and obesity at Cincinnati Children's Hospital Medical Center. I am a Professor at the University of Cincinnati, the Program Director of our Advanced Nutrition Fellowship and the Associate Program Director of our Steatohepatitis Center. My clinical research is focused on MASLD.

Dr. Espy Schaefer is a hepatologist and GI/liver hospitalist at Mass General Brigham, where she has served on the faculty since completing her residency and GI fellowship at MGH. She holds an undergraduate degree from Yale and an MD/MPH from Columbia University. After starting her research career as a basic and translational investigator in viral hepatitis, she co-founded the MGB alcohol liver disease clinic and biorepository which forms the basis of much of her current clinical research, including integrated addiction and hepatology care and biomarkers in ALD. Dr.

I am a transplant hepatologist at Thomas Jeffersno University. I have a special interest in alcohol associated liver disease and alcohol use disorder.

Dr. Rebecca Roediger's clinical and research interest focuses on advancing innovative models of integrated care for patients with alcohol related liver disease and alcohol use disorder. She is a transplant hepatologist at Weill Cornell Medicine and Medical Director of the Center for Alcohol and Liver Medicine, an integrated addiction and hepatology program dedicated to the treatment of alcohol-associated liver disease. She previously established and served as Medical Director of METRIC, Montefiore Einstein's multidisciplinary alcohol-related liver disease clinic. Dr.

I am an Associate Professor of Medicine in the Karsh Division of Gastroenterology and Hepatology and serve as Medical Director of the Liver Cancer Program at Cedars-Sinai Cancer. My research focuses on clinical and translational studies in liver cancer, with particular expertise in liver cirrhosis epidemiology, risk stratification, surveillance, early cancer detection, diagnosis, and treatment.